Sexual Dysfunction Check-up in Premenopausal Breast Cancer Survivors Taking Endocrine Therapy: A Cross-Sectional Study

Launched by CANDIOLO CANCER INSTITUTE - IRCCS · Jun 12, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at sexual dysfunction (SD) in women who have survived breast cancer and are currently taking hormone therapy after surgery. The main goal is to find out how common sexual dysfunction is in these patients and how it affects their quality of life. The study will also explore the specific symptoms that women experience and how these may relate to the type of surgery they had or the treatment they are receiving.

To participate, women between the ages of 18 and 55 who have had surgery for early-stage breast cancer and have been on hormone therapy for at least three months may be eligible. Participants will need to agree to take part in the study and complete some questionnaires. This research aims to gather important information that could help develop future treatments to improve sexual health for breast cancer survivors. If you or someone you know fits these criteria and is interested, this could be a valuable opportunity to contribute to understanding and improving care for women in similar situations.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • women aged ≥18 and ≤ 55
• • who underwent surgery for early stage breast cancer
• • taking endocrine therapy for at least 3 months
• • providing an informed consent and completing the study questionnaires.
• Exclusion Criteria:
• • withdrawal of the informed consent, at any time